The Joint Blog

Syndicate content TheJointBlog
Cannabis news and information
Updated: 21 hours 10 min ago

Study Finds Cannabinoids May Effectively Treat Obstructive Sleep Apnea

Tue, 11/14/2017 - 02:25
Results of a new study “support the therapeutic potential of cannabinoids in patients with OSA [obstructive sleep apnea]”.

For the study, published in the journal Sleep and epublished ahead of print by the National Institute of Health, “73 adults with moderate or severe OSA received either placebo (N=25), 2.5mg dronabinol (N=21) or 10mg dronabinol (N=27) daily, one hour before bedtime for up to 6 weeks.” Dronabinol, also called Marinol, is a synthetic THC meant to mimic the effects of natural, cannabis-based THC.

‘These findings support the therapeutic potential of cannabinoids in patients with OSA” states the study’s abstract. “In comparison to placebo, dronabinol was associated with lower AHI [Apnea–hypopnea index], improved subjective sleepiness and greater overall treatment satisfaction. Larger scale clinical trials will be necessary to clarify the best potential approach(es) to cannabinoid therapy in OSA.”

The full study can be found by clicking here.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Study Finds Cannabinoids May Effectively Treat Obstructive Sleep Apnea appeared first on TheJointBlog.

Hemp Foods Now Legal in Australia

Tue, 11/14/2017 - 02:16
As of yesterday, November 12th, hemp food products are legal in Australia.

Toasted hemp seeds.

The new changes to the Food Standards Code were approved in April. The changes legalizes sale of low-THC hemp seed for use as food or to be placed in food products (such as cereals and baked goods). For hemp seed to be legally used as food, it  must contain less than 0.5% THC, which is the psychoactive ingredient found in the cannabis plant and found in minuscule amounts in hemp plants.

“Historically, hemp has been used as a source of fibre and oil”, states a press release from the Australian government. “Hemp seeds and oil are used in other countries, including in Europe, Canada and the United States of America, in a range of foods. Hemp seeds contain protein, vitamins, minerals and polyunsaturated fatty acids, particularly omega-3 fatty acids.”

In Australia hemp has been legal for some time now for various uses including textiles and body care products. However, now is the first time hemp has been legal for consumption.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Hemp Foods Now Legal in Australia appeared first on TheJointBlog.

Study: CBD a “Therapeutic Candidate for Stroke Prevention”

Sun, 11/12/2017 - 09:00
Cannabidiol (CBD) may help to prevent strokes, according to a new study published by the U.S. National Institute of Health.

“The endocannabinoid system (ECS) regulates functions throughout human physiology, including neuropsychiatric, cardiovascular, autonomic, metabolic, and inflammatory states”, begins the study’s abstract, which was published in-print by the journal Cannabis and Cannabinoid Research. “The complex cellular interactions regulated by the ECS suggest a potential for vascular disease and stroke prevention by augmenting central nervous and immune cell endocannabinoid signaling.”

Cannabidiol (CBD), a nonpsychoactive constituent of Cannabis, “is an immediate therapeutic candidate both for potentiating endocannabinoid signaling and for acting at multiple pharmacological targets.” According to reseachers, this “speculative synthesis explores the current state of knowledge of the ECS and suggests CBD as a therapeutic candidate for stroke prevention by exerting favorable augmentation of the homeostatic effects of the ECS and, in turn, improving the metabolic syndrome, while simultaneously stalling the development of atherosclerosis.”

The full study, conducted by researchers at Mayo Clinic’s Department of Neurology, can be found by clicking here.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Study: CBD a “Therapeutic Candidate for Stroke Prevention” appeared first on TheJointBlog.

New York Governor Signs Bill Allowing Medical Cannabis for PTSD

Sat, 11/11/2017 - 20:21
New York Governor Andrew Cuomo has signed into law a bill that allows the medical use of cannabis for those with post traumatic stress disorder (PTSD).

The bipartisan legislation (A7006) adds PTSD to New York’s medical cannabis program, allowing those with the condition to become legal medical cannabis patients. As with other conditions that are part of the state’s medical cannabis program, those with PTSD will need to receive a recommendation from a physician and register with the state before they can legally purchase and use medical cannabis. Governor Cuomo signed the bill today, on Veterans Day.

A7006 received widespread, bipartisan support in New York’s Legislature. It was approved by the Assembly in May with a vote of 131 to 8, and was subsequential passed by the Senate 50 to 13. New York now becomes the 28th state to allow medical cannabis for PTSD.

“We thank Gov. Cuomo for his support of this compassionate bill. No one should have to leave the state to have access to a treatment that might help them have a better quality of life,” said Landon Dais, political director for the Marijuana Policy Project of New York.

Assembly Health Committee chair Richard N. Gottfried, sponsor of the bill, said, “Governor Cuomo’s action reflects growing recognition of the value of medical marijuana, and is another welcome step in the expanding and strengthening of New York’s medical marijuana program.”

“Gov. Cuomo should be applauded for helping thousands of New York veterans find relief with medical marijuana,” said Bob Becker, legislative director for the New York State Council of Veterans Organizations. “PTSD is a serious problem facing our state, and now we have one more tool available to alleviate suffering.”

Twenty-eight of the 29 states with medical marijuana programs will now allow patients with PTSD to qualify. In the only state that does not, Alaska, marijuana is legal and regulated for adults 21 and older. Bills to add PTSD to state medical marijuana programs were signed into law in Colorado, New Hampshire, and Vermont this year.

“Now, PTSD patients will have access to medical marijuana everywhere it is legally available,” Dais said. “Over the past two years, New York has made important strides toward having an inclusive, workable medical marijuana program. We urge legislators, Gov. Cuomo, and the Department of Health to continue improving the program. To better serve patients, the state should expand qualifying conditions, allow patients to use the type of cannabis products that work best for them, and reduce burdensome rules that drive up prices.”

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post New York Governor Signs Bill Allowing Medical Cannabis for PTSD appeared first on TheJointBlog.

Cannabis May Treat Migraines, Finds New Study

Sat, 11/11/2017 - 06:59
Findings from a new study published in the journal European Journal of Pharmacology shows that cannabis may serve as an effective treatment for migraine headaches.

“Current anti-migraine treatments have limited efficacy and many side effects”, begins the abstract of the study. “Although anecdotal evidence suggests that marijuana is useful for migraine, this hypothesis has not been tested in a controlled experiment.” Thus, the present study “tested whether administration of ∆9-tetrahydrocannabinol (THC) produces anti-migraine effects in the female rat.”

The results from the study “suggest that: 1) THC reduces migraine-like pain when administered at the right dose (0.32mg/kg) and time; 2) THC’s anti-migraine effect is mediated by CB1 receptors. These findings “support anecdotal evidence for the use of cannabinoids as a treatment for migraine in humans and implicate the CB1 receptor as a therapeutic target for migraine.”

The full study, conducted by researchers at Washington State University and Washington State University Vancouver, can be found by clicking here.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Cannabis May Treat Migraines, Finds New Study appeared first on TheJointBlog.

Voters in Athens, Ohio Vote to Depenalize up to 200 Grams of Marijuana, 10 Grams of Hash

Fri, 11/10/2017 - 04:14

By NORML

The Athens Cannabis Ordinance – better known as “TACO” – to completely remove all penalties for possessing, cultivating, and gifting of up to 200 grams of marijuana was approved by voters on election day by a vote of 77 percent to 23 percent.

In November 2016, four Ohio municipalities – Newark, Logan, Roseville, and Bellaire – passed similar depenalization ballot measures. Under Ohio state law, minor marijuana possession offenses are classified as a minor misdemeanor, punishable by a fine, but no jail time or criminal record.

“Voters overwhelmingly approved of TACO because the continued criminalization of adult marijuana use is out-of-step with the views of the vast majority of adults in the United States, 64 percent of whom now endorse legalizing and regulating cannabis,” said Justin Strekal, NORML Political Director. “While politicians continue to drag their feet, citizens are showing leadership at the local and state level in jurisdictions where the ability to achieve marijuana reform is possible at the ballot box.”

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Voters in Athens, Ohio Vote to Depenalize up to 200 Grams of Marijuana, 10 Grams of Hash appeared first on TheJointBlog.

Study: Low-Doses of THC May Reverse Cognitive Impairment in Aging Humans

Thu, 11/09/2017 - 10:17
According to an important new study published by the journal Neurobiology of Aging has found that low-doses of THC “may provide a safe and effective treatment for cognitive decline in aging humans”.

“This study was designed to test our hypothesis that an ultra-low dose of delta-9 tetrahydrocannabinol (THC) reverses age-dependent cognitive impairments in old mice and to examine the possible biological mechanisms that underlie this behavioral effect”, states the study’s abstract. “Old female mice aged 24 months that had been injected once with 0.002 mg/kg THC (3-4 orders of magnitudes lower than doses that induce the conventional cannabinoid effects in mice) performed significantly better than vehicle-treated old mice and performed similarly to naive young mice aged 2 months, in 6 different behavioral assays that measured various aspects of memory and learning.” The beneficial effect of THC lasted for at least 7 weeks.

The study states that; “The single injection of THC increased the level of Sirtuin1, an enzyme that has been previously shown to be involved in neuroprotection and neuroplasticity, in the hippocampus and in the frontal cortex of old mice”.

The study concludes by stating that; “These findings suggest that extremely low doses of THC that are devoid of any psychotropic effect and do not induce desensitization may provide a safe and effective treatment for cognitive decline in aging humans.”

The study, epublished ahead of print by the U.S. National Institute of Health, can be found by clicking here.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Study: Low-Doses of THC May Reverse Cognitive Impairment in Aging Humans appeared first on TheJointBlog.

Study: Cannabis May Treat Parkinson’s Disease and Other Movement Disorders

Thu, 11/09/2017 - 10:09
Cannabis have be an effective treatment option for those with Parkinson’s disease and other movement disorders, according to a new study published in the journal Molecular Psychiatry.

“Cannabis and related compounds have recently been studied as promising therapeutic agents in treatment of neurodegenerative and movement disorders including Parkinson’s disease”, begins the study’s abstract. “In this review we have examined the potential benefits of medical marijuana and cannabinoids in the treatment of both motor and nonmotor symptoms as well as in slowing the progression of the disease. We have looked into any scientific evidence that indicates the potential use of marijuana and/or related compounds for the treatment of PD.”

According to researchers; “Current treatments of PD provide only relief of motor symptoms and are associated with adverse effects such as dyskinesia. In addition, these therapies do not slow the progression of the disease.” Therefore, “there is an urgent need for safer drugs that can treat both motor and nonmotor symptoms of PD as well as drugs that slow the progression of the disease.”

The study states that research studies “have provided evidence for the potential effectiveness of medical marijuana and its components in the treatment of PD as cannabinoids act on the same neurological pathway that is disrupted in Parkinson’s disease. Involvement of the endocannabinoid system in the regulation of motor behavior, the localization of the cannabinoid receptors in areas that control movement, and the effect of cannabinoids on motor activity indicate that cannabinoids can be potentially used in the treatment of movement disorders.”

Researchers claim that cannabis “has been shown to improve nonmotor symptoms of PD such as depression, pain, sleep, and anxiety. Moreover, components of cannabis have been demonstrated to have neuroprotective effect due to their anti-inflammatory, antioxidative, and antiexcitotoxic properties.”

The study concludes that; “Due to combination of the above mentioned beneficial effects, cannabis may provide a viable alternative or addition to the current treatment of Parkinson’s disease.”

The full study can be found by clicking here.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Study: Cannabis May Treat Parkinson’s Disease and Other Movement Disorders appeared first on TheJointBlog.

Wisconsin Senate Unanimously Approves Bill to Legalize Hemp

Thu, 11/09/2017 - 09:46
The Wisconsin Senate has unanimously approved a measure that would legalize the production and cultivation of industrial hemp.

The Senate approved the hemp legalization measure with a vote of 33 to 0, sending it to the state’s Assembly. The Assembly is expected to pass the bill, which could happen as soon as today. If approved by the Assembly the measure would be sent to Governor Scott Walker who would have the option of signing it into law, allowing it to become law without his signature or vetoing it (though a veto could be overturned by a 2/3rds vote in the legislature).

Under the proposed law, a system of state licenses would be established that could be obtained by farmers in order to legally grow and cultivate hemp. The legislation initially labelled hemp as having no more than 1% THC, but the Senate amended it so that the maximum THC is 0.3%; hemp being grown above this level would be illegal.

If the measure becomes law, Wisconsin would join theover 30 states that have legalized hemp.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Wisconsin Senate Unanimously Approves Bill to Legalize Hemp appeared first on TheJointBlog.

New Jersey Governor-Elect Vows to Legalize Marijuana in First 100 Days

Thu, 11/09/2017 - 07:34
New Jersey voters have elected Philip D. Murphy as their next governor.

New Jersey Governor-elect Philip Murphy.

The election of Governor-elect Murphy comes as amazing news to advocates of marijuana legalization; the former Wall Street banker says he has a plan to legalize marijuana in his first 100 days in office. If successful, New Jersey would become the 9th state to legalize marijuana for personal use.

Governor-elect Murphy’s position on legalizing marijuana couldn’t be further from the position of outgoing Governor Chris Christie, who staunchly opposes legalization and has done everything in his power to weaken the state’s medical cannabis program. Christie is leaving office with the lowest approval rating for a governor in New Jersey history.

In May, State Senator Nicholas Scutari (D-Union) unveiled a proposal that would legalize marijuana for those 21 and older, establishing a system of licensed and regulated cannabis retail outlets and cultivation centers. According to statewide Rutgers-Eagleton poll, 58% of voters in New Jersey support the move to legalize marijuana for adults.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post New Jersey Governor-Elect Vows to Legalize Marijuana in First 100 Days appeared first on TheJointBlog.

California Initiative Would Legalize Magic Mushrooms

Mon, 11/06/2017 - 19:44
Proponents of a California initiative to legalize psilocybin (“magic”) mushrooms have been cleared by Secretary of State Alex Padilla to begin collecting signatures.

Psilocybin mushrooms.

Advocates of the California Psilocybin Legalization Initiative (Initiative 17-0024) are aiming to place the initiative on the 2018 general election. To do so, they must collect signatures from 365,880 registered California voters by the end of April.

If placed on the ballot and passed into law by voters, the initiative – introduced by Marina mayoral candidate Kevin Saunders – would eliminate all criminal penalties associated with magic mushrooms for those 21 and older. This includes removing penalties for “possessioin, sale, transport and cultivation of psilocybin”. If approved, California would become the first state in the U.S. to legalize magic mushrooms.

Under current law, those caught possessing magic mushrooms – even a small amount for personal use – can be charged with a misdemeanor and imprisoned for up to a year.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post California Initiative Would Legalize Magic Mushrooms appeared first on TheJointBlog.

Study: Those Who Use Psychedelics Less Likely to Commit Crimes

Mon, 11/06/2017 - 19:33
Consumers of psychedelics drugs such as magic mushrooms are less likely to commit various crimes, according to a new study published by the Journal of Psychopharmacology.

Psilocybin (“magic”) mushrooms.

“Some evidence suggests classic psychedelics may inhibit criminal behavior, but the extent of these effects has not been comprehensively explored”, states the study’s abstract. “In this study, we tested the relationships of classic psychedelic use and psilocybin use per se with criminal behavior among over 480,000 United States adult respondents pooled from the last 13 available years of the National Survey on Drug Use and Health (2002 through 2014) while controlling for numerous covariates.”

Lifetime classic psychedelic use “was associated with a reduced odds of past year larceny/theft, past year assault, past year arrest for a property crime , and past year arrest for a violent crime.” In contrast, “lifetime illicit use of other drugs was, by and large, associated with an increased odds of these outcomes. Lifetime classic psychedelic use, like lifetime illicit use of almost all other substances, was associated with an increased odds of past year drug distribution.”

According to researchers; “Results were consistent with a protective effect of psilocybin for antisocial criminal behavior.”

The study concludes by stating that; “These findings contribute to a compelling rationale for the initiation of clinical research with classic psychedelics, including psilocybin, in forensic settings.”

The full study can be found by clicking here.

 

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Study: Those Who Use Psychedelics Less Likely to Commit Crimes appeared first on TheJointBlog.

California Company Becomes First to Offer Commercial Insurance to Marijuana Businesses

Mon, 11/06/2017 - 08:35
California Insurance Commissioner Dave Jones has announced that for the first time legal marijuana businesses in the state now have an insurance company willing to offer them commercial insurance.

According to Jones, legal marijuana businesses are now able to purchase commercial insurance from Golden Bear Insurance Company, the first company willing to offer such services to the marijuana industry. The insurer was given approval last week to began providing commercial insurance to marijuana businesses that are explicitly following state law.

“Consumers who visit cannabis businesses, workers who work there, businesses who sell products to or rent property to cannabis businesses, and the investors, owners and operators of cannabis businesses all should have insurance coverage available to help them recover when something goes wrong just as any other legalized business does,” said commissioner Jones in a statement.

Although Golden Bear Insurance Company isn’t the first company in the state to provide insurance for the marijuana industry (there are currently 25 carriers that provide riskier forms of insurance), but they are the first to offer commercial insurance.

When asked about the potential risk of insurers working with the marijuana industry due to the Trump campaign, Jones says: “We believe the risk of federal intervention with an insurer is low. The fact that 25 surplus lines carriers are writing insurance currently demonstrates this.”

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post California Company Becomes First to Offer Commercial Insurance to Marijuana Businesses appeared first on TheJointBlog.

Walgreens Stocking Overdose Reversal Drug in Stores Nationwide, No Prescription Needed

Mon, 11/06/2017 - 00:38
As part of its “comprehensive national plan to combat drug abuse”, Walgreens is now stocking Narcan (Nalaxone), an FDA-approved nasal spray that helps reverse opioid overdoses, in all of its more than 8,000 pharmacies nationwide. 

“By stocking Narcan in all our pharmacies, we are making it easier for families and caregivers to help their loved ones by having it on hand in case it is needed,” Rick Gates, Walgreens group vice president of pharmacy, said in a press release. “As a pharmacy we are committed to making Narcan more accessible in the communities we serve.”

In addition, Walgreens is adopting Centers for Disease Control and Prevention (CDC) recommendations by educating patients about Narcan when they are dispensed a controlled substance greater than 50 morphine milligram equivalents (MME) and may be at risk of accidental overdose.

“This action is an important milestone and we applaud Walgreens initiatives to improve access to Narcan Nasal Spray in communities across the U.S.,” said Seamus Mulligan, Chief Executive Officer of Adapt Pharma, the manufacturer of Narcan Nasal Spray. “This effort, combined with the opportunity for patients and caregivers to obtain Narcan Nasal Spray without an individual prescription in 45 states, is critical in combating this crisis.”

In an effort to educate the public on use of naloxone, pharmaceutical wholesaler AmerisourceBergen has distributed Narcan demo devices at no cost to Walgreens pharmacists for use in instructing patients on how to administer the medication. Additional instructions include calling 911, as Narcan is not a substitute for medical care. Anyone who is administered the medication should seek immediate medical attention.

“At AmerisourceBergen, we strive to provide our customers the highest quality care and support so they can ultimately enhance the lives of patients in their communities,” said Robert Mauch, Executive Vice President & Group President, Pharmaceutical Distribution & Strategic Global Sourcing for AmerisourceBergen. “We recognize the important role we play in addressing the opioid epidemic, and our collaboration with Walgreens is another key milestone to supply our customers with access to lifesaving initiatives and emergency medications that can help keep individuals safe across the country.”

Last year Walgreens announced an effort to make naloxone available without requiring a prescription in states where regulations allow. The company now offers naloxone without requiring a prescription in 45 states and is eager and willing to work with the remaining states to make naloxone easier to obtain.

Walgreens has also collected more than 155 tons of unwanted medications through its safe medication disposal kiosks in 600 pharmacies across 45 states and Washington D.C. The kiosks allow individuals to safely and conveniently dispose of unwanted prescriptions, including controlled substances and over-the-counter medications, year-round at no cost.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Walgreens Stocking Overdose Reversal Drug in Stores Nationwide, No Prescription Needed appeared first on TheJointBlog.

Ontario Announces the First 14 Cities to Have Legal Marijuana Stores

Sun, 11/05/2017 - 06:50
The Liquor Control Board of Ontario has announced the first cities that will be home to legal marijuana stores.

Last month Ontario officials unveiled their framework for the legal marijuana industry, which includes having 150 marijuana stores open by 2020, with online sales beginning next year. Yesterday, the Liquor Control Board announced the first 14 cities where legal marijuana outlets will be open.

Those cities will be:

  • Brampton
  • Vaughan
  • Toronto
  • London

  • Mississauga
  • Hamilton Barrie
  • Kingston, Kitchener
  • Sault Ste. Marie
  • Ottawa
  • Thunder Bay
  • Windsor
  • Sudbury

Ontario is the first province or territory in Canada to put forth a comprehensive plan for the legal marijuana industry. The plan includes allowing those 19 and older to legally purchase marijuana from marijuana stores overseen by the Liquor Control Board.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Ontario Announces the First 14 Cities to Have Legal Marijuana Stores appeared first on TheJointBlog.

Belize Decriminalizes Marijuana Possession

Fri, 11/03/2017 - 21:30
The country of Belize has officially decriminalized the possession of small amounts of marijuana for personal use.

Belize Governor General Colville Young signed into law today a bill decriminalizing the possession of up to 10 grams of marijuana. The bill “provides for the imposition of monetary and non-recordable penalties for the possession of cannabis in such amounts occurring on school premises, in specified circumstances, and decriminalizes the smoking of cannabis on private premises.”

“I think this act will also allow for law enforcement personnel and the ministry to focus and concentrate more on the serious crimes that are affecting and plaguing our societies and our communities across this country and like the leader of the opposition said he would have wanted to see the whole legalization of marijuana, but I believe that it is prudent that we as a responsible government take this one step at a time as we progress to ensure that we always make the right decision that will be a betterment for our nation”, said Hon. Wilfred Elrington, Belize’s Minister of Home Affairs, following the bill’s approval in the House of Representatives.

Belize, a country in Central America, has a population of roughly 366,000.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Belize Decriminalizes Marijuana Possession appeared first on TheJointBlog.

Poll: Overwhelming Majority of Veterans Support Medical Cannabis

Fri, 11/03/2017 - 18:35
According to a new survey commissioned by the American Legion, a vast majority of Veterans in the U.S. are in support of cannabis as medicine.

According to the survey, 81% of veterans support legalizing medical cannabis at the federal level. An even higher number of veteran caregivers are in support, at 83%.

The survey had 1,360 respondents from across the U.S., with 802 being either a military veteran (513) or a non-professional veteran caregiver (289). 92% of respondents from both groups support medical research on cannabis, while 82% of respondents favor legalizing medical cannabis. Support was found across the political spectrum, with 88% of conservatives  supporting medical cannabis legalization, compared to 90% of liberals and 70% of those who consider themselves non aligned with any particular ideology.

The poll has a margin of error  plus or minus 3.43%

servative respondents, as well as 90% of self-identified liberals and 70% of self-identified non-partisans, support federally legalized medical cannabis.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Poll: Overwhelming Majority of Veterans Support Medical Cannabis appeared first on TheJointBlog.

Court Rules New Jersey Must Consider Reclassifying Marijuana

Wed, 11/01/2017 - 22:25
The Appellate Division of the New Jersey Superior Court has ruled that the state must consider reclassifying marijuana due to the fact that marijuana’s health benefits are “abundantly and glaringly apparent now”.

The court ruled that Steve Lee, former director of the Division of Consumer Affairs, had the legal authority to reclassify marijuana away from Schedule 1 when he denied a request in 2014. The ruling says states that since New Jersey has now had a long-running medical marijuana program, the government must revisit the issue and again consider whether marijuana should be removed as a Schedule 1 drug, which indicates it has no medical value and is as dangerous as substances such as heroin.

According to Attorney Joseph Linares of Newark, who brought forth the case on behalf of inmate Steven Kadonsky, the state may decide to keep marijuana a Schedule 1 drug following the ruling, though they can’t do so because the substance has no medical value.

Linares says the ruling is “an important incremental step” toward reclassifying marijuana. “What this decision does recognize is the widespread acceptance of marijuana use in medical treatment,” says Linares.

To view the full 42-page ruling, click here.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Court Rules New Jersey Must Consider Reclassifying Marijuana appeared first on TheJointBlog.

FDA Sends Warning to CBD Companies

Wed, 11/01/2017 - 22:11
The Food and Drug Administration (FDA) has sent warning letters to multiple companies involved in the distribution of products containing cannabidiol (CBD).

fdaThe FDA sent warning letters today to four CBD-related companies claiming them to be making unsubstantiated claims “related to more than 25 different products spanning multiple product webpages, online stores and social media websites”. The companies are Natural Alchemist (California), Greenroads Health (Florida), That’s Natural! Marketing & Consulting (Colorado), and Stanley Brothers Social Enterprises LLC (also Colorado).

“As part of the U.S. Food and Drug Administration’s ongoing efforts to protect consumers from health fraud, the agency today issued warning letters to four companies illegally selling products online that claim to prevent, diagnose, treat, or cure cancer without evidence to support these outcomes”, states a Wednesday press release. “Selling these unapproved products with unsubstantiated therapeutic claims is not only a violation of the Federal Food, Drug and Cosmetic Act, but also can put patients at risk as these products have not been proven to be safe or effective. The deceptive marketing of unproven treatments may keep some patients from accessing appropriate, recognized therapies to treat serious and even fatal diseases.”

The release states that the FDA “has grown increasingly concerned at the proliferation of products claiming to treat or cure serious diseases like cancer. In this case, the illegally sold products allegedly contain cannabidiol (CBD), a component of the marijuana plant that is not FDA approved in any drug product for any indication.” The companies receiving warning letters “distributed the products with unsubstantiated claims regarding preventing, reversing or curing cancer; killing/inhibiting cancer cells or tumors; or other similar anti-cancer claims. Some of the products were also marketed as an alternative or additional treatment for Alzheimer’s and other serious diseases.”

“Substances that contain components of marijuana will be treated like any other products that make unproven claims to shrink cancer tumors”, said FDA Commissioner Scott Gottlieb “We don’t let companies market products that deliberately prey on sick people with baseless claims that their substance can shrink or cure cancer and we’re not going to look the other way on enforcing these principles when it comes to marijuana-containing products.”

According to The Cannabist, the FDA issued similar warning letters to CBD product makers in 2015 and 2016.

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post FDA Sends Warning to CBD Companies appeared first on TheJointBlog.

Here is the First Fortune 500 Marijuana Stock

Tue, 10/31/2017 - 18:43

By Charles Bovaird, Investopedia.com

Constellation Brands, Inc. (STZ)—a Fortune 500 company that owns brands such as Corona beer, Black Velvet Whisky and Casa Noble tequila—recently agreed to take a 9.9% stake in Canadian marijuana company Canopy Growth Corp. (TWMJF). The two companies plan to work together to develop and market beverages that will be infused with Cannabis, according to The Wall Street Journal. (For more, see also: Top 4 Marijuana Stocks to Watch.)

Legalization Spreads

Rob Sands, president and CEO of Constellation Brands, told The Journal that the U.S. government will probably legalize marijuana at the federal level in the coming years, considering “what’s happened at the state level.” Even if these expectations don’t materialize, his company could sell marijuana-infused beverages in Canada, where they are expected to be legalized by 2019.

Since Canopy Growth is the world’s largest publicly traded marijuana company, the decision made by Constellation Brands gives the beverage maker a strong presence in the marijuana industry, The Journal reported.

Shifting Demographics

Constellation Brands made this move at a time when there is evidence that some consumers are reducing their alcohol consumption in favor of marijuana, according to Fortune.

“We believe alcohol could be under pressure for the next decade,” analysts for Cowen Inc. (COWN), led by Viven Azer, wrote in a note earlier this year, Fortune reported. “Consumer survey work suggests [about] 80% of consumers reduce their alcohol consumption with cannabis in the mix.”

Currently, 28 states and the District of Columbia have legalized marijuana in one capacity or another, according to The Journal. Should more states permit the use of this drug, consumption could rise sharply, providing a strong market for edibles that are infused with marijuana. (For more, see also: Which States Have Legal Pot & Will It Stay Legal?)

MANTIS_RECOMMEND = { property: '53d026bdee55332b7d413198', render: 'mantis__recommended__wordpress' };

var z = document.createElement("script"); z.type = "text/javascript"; z.async = true; z.src = "//assets.mantisadnetwork.com/recommend.min.js"; var s = document.getElementsByTagName('head')[0]; s.parentNode.insertBefore(z, s);

The post Here is the First Fortune 500 Marijuana Stock appeared first on TheJointBlog.